-DOCSTART- -X- O
The -X- _ O
number -X- _ O
of -X- _ O
patients -X- _ O
receiving -X- _ O
hematopoietic -X- _ B-Patient
stem -X- _ I-Patient
cell -X- _ I-Patient
transplantation -X- _ I-Patient
( -X- _ I-Patient
HSCT -X- _ I-Patient
) -X- _ I-Patient
is -X- _ O
rapidly -X- _ O
rising -X- _ O
worldwide. -X- _ O
Despite -X- _ O
substantial -X- _ O
improvements -X- _ O
in -X- _ O
peri-transplant -X- _ O
care -X- _ O
, -X- _ O
pulmonary -X- _ O
complications -X- _ O
resulting -X- _ O
in -X- _ O
respiratory -X- _ O
failure -X- _ O
remain -X- _ O
a -X- _ O
major -X- _ O
contributor -X- _ O
to -X- _ O
morbidity -X- _ O
and -X- _ O
mortality -X- _ O
in -X- _ O
the -X- _ O
post- -X- _ O
transplant -X- _ O
period -X- _ O
, -X- _ O
and -X- _ O
represent -X- _ O
a -X- _ O
major -X- _ O
barrier -X- _ O
to -X- _ O
the -X- _ O
overall -X- _ O
success -X- _ O
of -X- _ O
HSCT. -X- _ O
Infectious -X- _ O
complications -X- _ O
include -X- _ O
pneumonia -X- _ B-Outcome
due -X- _ I-Outcome
to -X- _ I-Outcome
bacteria -X- _ I-Outcome
, -X- _ I-Outcome
viruses -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
fungi -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
most -X- _ I-Outcome
commonly -X- _ I-Outcome
occur -X- _ I-Outcome
during -X- _ I-Outcome
neutropenia -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
early -X- _ I-Outcome
post-transplant -X- _ I-Outcome
period. -X- _ I-Outcome
Non-infectious -X- _ I-Outcome
complications -X- _ I-Outcome
include -X- _ I-Outcome
idiopathic -X- _ I-Outcome
pneumonia -X- _ I-Outcome
syndrome -X- _ I-Outcome
, -X- _ I-Outcome
peri-engraftment -X- _ I-Outcome
respiratory -X- _ I-Outcome
distress -X- _ I-Outcome
syndrome -X- _ I-Outcome
, -X- _ I-Outcome
diffuse -X- _ I-Outcome
alveolar -X- _ I-Outcome
hemorrhage -X- _ I-Outcome
, -X- _ I-Outcome
pulmonary -X- _ I-Outcome
veno-occlusive -X- _ I-Outcome
disease -X- _ I-Outcome
, -X- _ I-Outcome
delayed -X- _ I-Outcome
pulmonary -X- _ I-Outcome
toxicity -X- _ I-Outcome
syndrome -X- _ I-Outcome
, -X- _ I-Outcome
cryptogenic -X- _ I-Outcome
organizing -X- _ I-Outcome
pneumonia -X- _ I-Outcome
, -X- _ I-Outcome
bronchiolitis -X- _ I-Outcome
obliterans -X- _ I-Outcome
syndrome -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
post-transplant -X- _ I-Outcome
lymphoproliferative -X- _ I-Outcome
disorder. -X- _ I-Outcome
These -X- _ O
complications -X- _ O
have -X- _ O
distinct -X- _ O
clinical -X- _ O
features -X- _ O
and -X- _ O
risk -X- _ O
factors -X- _ O
, -X- _ O
occur -X- _ O
at -X- _ O
differing -X- _ O
times -X- _ O
following -X- _ O
transplant -X- _ O
, -X- _ O
and -X- _ O
contribute -X- _ O
to -X- _ O
morbidity -X- _ O
and -X- _ O
mortality -X- _ O
. -X- _ O

